The first pregnant woman infected with malaria has been recruited into a Phase 3 trial in Mali that is evaluating the efficacy and safety of antimalarial drugs during the first trimester of pregnancy. Pregnant women are more susceptible to malaria as they have reduced immunity, and malaria poses serious risks to both mothers and babies. […] Continue reading ->
Two Indian manufacturers will be able to mass-produce cheap generic versions of the HIV ‘miracle’ drug, lenacapavir, which almost eliminates HIV transmission via an injection given twice a year – thanks to support from donors. The Gates Foundation will support Hetero Labs, while Unitaid, the Clinton Health Access Initiative (CHAI), and Wits RHI will support Dr […] Continue reading ->
WHO has ended its declaration of a Public Health Emergency of International Concern (PHEIC) for Mpox, announced in August 2024, saying that cases in the most affected areas of Africa had leveled off or were declining. However, continued vigilance in testing – along with regular supplies of vaccines and drug treatments remains essential to ensure […] Continue reading ->
The World Health Organization (WHO) has designated government regulatory authorities in Canada, Japan, and the United Kingdom as WHO-Listed Authorities (WLAs), a status granted to national authorities that meet the highest international regulatory standards for medical products. The recognition widens the pool of WHO-recognized authorities significantly beyond the previously recognized authorities in Europe, the United […] Continue reading ->